Sunita D. Srivastava, M.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Blood Vessel Prosthesis Implantation | 18 | 2023 | 1390 | 1.830 |
Why?
|
| Aortic Aneurysm, Abdominal | 12 | 2023 | 1186 | 1.250 |
Why?
|
| Endovascular Procedures | 8 | 2023 | 1979 | 1.000 |
Why?
|
| Journal Impact Factor | 1 | 2022 | 156 | 0.730 |
Why?
|
| Authorship | 1 | 2022 | 271 | 0.660 |
Why?
|
| Physicians, Women | 2 | 2022 | 486 | 0.650 |
Why?
|
| Blood Vessel Prosthesis | 7 | 2022 | 933 | 0.520 |
Why?
|
| Aneurysm | 3 | 2013 | 339 | 0.450 |
Why?
|
| Graft Occlusion, Vascular | 4 | 2023 | 549 | 0.410 |
Why?
|
| Periodicals as Topic | 1 | 2022 | 1432 | 0.370 |
Why?
|
| Viscera | 1 | 2010 | 139 | 0.360 |
Why?
|
| Vascular Surgical Procedures | 5 | 2011 | 1475 | 0.340 |
Why?
|
| Carotid Artery Diseases | 2 | 2011 | 882 | 0.290 |
Why?
|
| Biomedical Research | 1 | 2022 | 3309 | 0.270 |
Why?
|
| Vascular Patency | 6 | 2023 | 886 | 0.270 |
Why?
|
| Endoleak | 3 | 2015 | 106 | 0.250 |
Why?
|
| Peripheral Vascular Diseases | 1 | 2008 | 550 | 0.250 |
Why?
|
| Aortic Aneurysm, Thoracic | 1 | 2010 | 686 | 0.230 |
Why?
|
| Venous Thrombosis | 1 | 2013 | 1239 | 0.230 |
Why?
|
| Urinary Retention | 1 | 2023 | 111 | 0.210 |
Why?
|
| Stents | 10 | 2011 | 3280 | 0.210 |
Why?
|
| Diverticulum | 1 | 2021 | 136 | 0.180 |
Why?
|
| Anticoagulants | 2 | 2013 | 4599 | 0.180 |
Why?
|
| Prosthesis Design | 4 | 2022 | 2110 | 0.170 |
Why?
|
| Device Removal | 2 | 2015 | 656 | 0.170 |
Why?
|
| Retrospective Studies | 17 | 2023 | 77449 | 0.170 |
Why?
|
| Endarterectomy, Carotid | 1 | 2023 | 546 | 0.160 |
Why?
|
| Angioplasty, Balloon | 3 | 2009 | 653 | 0.160 |
Why?
|
| Treatment Outcome | 16 | 2023 | 63114 | 0.150 |
Why?
|
| Vena Cava, Inferior | 1 | 2020 | 440 | 0.150 |
Why?
|
| Hypotension | 1 | 2023 | 884 | 0.150 |
Why?
|
| Chordoma | 1 | 2020 | 359 | 0.150 |
Why?
|
| Prosthesis Failure | 2 | 2013 | 1206 | 0.140 |
Why?
|
| Aortic Aneurysm | 2 | 2015 | 643 | 0.140 |
Why?
|
| Vascular System Injuries | 1 | 2020 | 250 | 0.140 |
Why?
|
| Accidental Falls | 1 | 2024 | 1062 | 0.140 |
Why?
|
| Free Tissue Flaps | 1 | 2020 | 328 | 0.130 |
Why?
|
| Bone Transplantation | 1 | 2020 | 907 | 0.130 |
Why?
|
| Iliac Artery | 2 | 2009 | 364 | 0.130 |
Why?
|
| Platelet Aggregation Inhibitors | 1 | 2008 | 3068 | 0.130 |
Why?
|
| Spinal Neoplasms | 1 | 2020 | 760 | 0.110 |
Why?
|
| Risk Factors | 10 | 2023 | 72290 | 0.110 |
Why?
|
| Arterial Occlusive Diseases | 2 | 2009 | 793 | 0.110 |
Why?
|
| After-Hours Care | 1 | 2013 | 102 | 0.110 |
Why?
|
| Natural Language Processing | 1 | 2020 | 1041 | 0.100 |
Why?
|
| Vascular Diseases | 1 | 2020 | 1161 | 0.100 |
Why?
|
| Pulmonary Embolism | 1 | 2004 | 2376 | 0.100 |
Why?
|
| Aorta, Abdominal | 2 | 2004 | 646 | 0.100 |
Why?
|
| Lumbar Vertebrae | 1 | 2020 | 1848 | 0.100 |
Why?
|
| Splenic Artery | 1 | 2011 | 54 | 0.090 |
Why?
|
| Aneurysm, Ruptured | 3 | 2011 | 452 | 0.090 |
Why?
|
| Aged | 18 | 2023 | 163280 | 0.090 |
Why?
|
| Emergencies | 2 | 2013 | 1170 | 0.090 |
Why?
|
| Life Tables | 1 | 2010 | 370 | 0.090 |
Why?
|
| Humans | 35 | 2024 | 744343 | 0.090 |
Why?
|
| Collateral Circulation | 1 | 2010 | 287 | 0.090 |
Why?
|
| Angiography | 3 | 2023 | 1639 | 0.080 |
Why?
|
| Patient Readmission | 1 | 2023 | 3114 | 0.080 |
Why?
|
| Sex Factors | 2 | 2022 | 10397 | 0.080 |
Why?
|
| Carotid Artery, Internal | 1 | 2011 | 445 | 0.080 |
Why?
|
| Postoperative Complications | 7 | 2023 | 15295 | 0.080 |
Why?
|
| Aneurysm, False | 1 | 2011 | 276 | 0.080 |
Why?
|
| Kaplan-Meier Estimate | 4 | 2013 | 6538 | 0.080 |
Why?
|
| Female | 20 | 2023 | 380194 | 0.070 |
Why?
|
| Ohio | 3 | 2013 | 337 | 0.070 |
Why?
|
| Physician-Patient Relations | 1 | 2020 | 3229 | 0.070 |
Why?
|
| Regional Blood Flow | 1 | 2010 | 1525 | 0.070 |
Why?
|
| Watchful Waiting | 1 | 2011 | 492 | 0.070 |
Why?
|
| Matrix Metalloproteinase 14 | 1 | 2006 | 61 | 0.070 |
Why?
|
| Aortography | 3 | 2015 | 437 | 0.070 |
Why?
|
| Inguinal Canal | 1 | 2006 | 69 | 0.070 |
Why?
|
| Time Factors | 12 | 2015 | 40075 | 0.070 |
Why?
|
| Foreign-Body Migration | 2 | 2004 | 222 | 0.060 |
Why?
|
| Male | 21 | 2024 | 350118 | 0.060 |
Why?
|
| Ultrasonography, Interventional | 1 | 2013 | 1486 | 0.060 |
Why?
|
| Heart Defects, Congenital | 1 | 2021 | 4584 | 0.060 |
Why?
|
| Mesenteric Artery, Superior | 1 | 2004 | 101 | 0.060 |
Why?
|
| Matrix Metalloproteinase 2 | 1 | 2006 | 472 | 0.060 |
Why?
|
| Hypertension | 1 | 2023 | 8480 | 0.060 |
Why?
|
| Carotid Artery, Internal, Dissection | 1 | 2003 | 45 | 0.060 |
Why?
|
| Angiotensin II | 1 | 2006 | 881 | 0.050 |
Why?
|
| Robotics | 1 | 2010 | 899 | 0.050 |
Why?
|
| Matrix Metalloproteinase 9 | 1 | 2006 | 638 | 0.050 |
Why?
|
| Aortic Diseases | 1 | 2009 | 742 | 0.050 |
Why?
|
| Carotid-Cavernous Sinus Fistula | 1 | 2003 | 40 | 0.050 |
Why?
|
| Renal Artery | 1 | 2004 | 398 | 0.050 |
Why?
|
| Aged, 80 and over | 9 | 2024 | 57776 | 0.050 |
Why?
|
| Reoperation | 5 | 2013 | 4201 | 0.050 |
Why?
|
| Gene Expression Regulation, Enzymologic | 1 | 2006 | 1213 | 0.050 |
Why?
|
| Subclavian Artery | 1 | 2021 | 130 | 0.050 |
Why?
|
| Tomography, X-Ray Computed | 8 | 2015 | 20129 | 0.050 |
Why?
|
| Angioplasty | 1 | 2003 | 364 | 0.050 |
Why?
|
| Internship and Residency | 1 | 2020 | 5788 | 0.050 |
Why?
|
| Radionuclide Imaging | 1 | 2004 | 2031 | 0.040 |
Why?
|
| Thrombolytic Therapy | 1 | 2009 | 2161 | 0.040 |
Why?
|
| Warfarin | 1 | 2008 | 1496 | 0.040 |
Why?
|
| Saphenous Vein | 1 | 2021 | 532 | 0.040 |
Why?
|
| Portal Vein | 1 | 2020 | 437 | 0.040 |
Why?
|
| Drug Therapy, Combination | 1 | 2008 | 6489 | 0.040 |
Why?
|
| Aorta | 1 | 2004 | 2061 | 0.040 |
Why?
|
| Middle Aged | 14 | 2020 | 213383 | 0.030 |
Why?
|
| Radiography | 2 | 2004 | 7023 | 0.030 |
Why?
|
| United States | 2 | 2023 | 69872 | 0.030 |
Why?
|
| Aspirin | 1 | 2008 | 3282 | 0.030 |
Why?
|
| Length of Stay | 2 | 2023 | 6309 | 0.030 |
Why?
|
| Aorta, Thoracic | 1 | 2021 | 1082 | 0.030 |
Why?
|
| Consensus | 1 | 2023 | 2959 | 0.030 |
Why?
|
| Antihypertensive Agents | 1 | 2023 | 2046 | 0.030 |
Why?
|
| Ischemia | 1 | 2021 | 1907 | 0.030 |
Why?
|
| Equipment Safety | 2 | 2003 | 264 | 0.030 |
Why?
|
| Academic Medical Centers | 1 | 2020 | 2759 | 0.020 |
Why?
|
| Neurosurgical Procedures | 1 | 2020 | 2002 | 0.020 |
Why?
|
| Adult | 5 | 2020 | 214055 | 0.020 |
Why?
|
| Quality Improvement | 1 | 2023 | 3749 | 0.020 |
Why?
|
| Prosthesis-Related Infections | 1 | 2013 | 538 | 0.020 |
Why?
|
| Treatment Failure | 1 | 2013 | 2618 | 0.020 |
Why?
|
| Survival Analysis | 3 | 2003 | 10252 | 0.020 |
Why?
|
| Disease Progression | 2 | 2013 | 13284 | 0.020 |
Why?
|
| Follow-Up Studies | 5 | 2006 | 39050 | 0.020 |
Why?
|
| Michigan | 1 | 2006 | 350 | 0.020 |
Why?
|
| Technology Transfer | 1 | 2004 | 44 | 0.020 |
Why?
|
| Chi-Square Distribution | 1 | 2011 | 3508 | 0.020 |
Why?
|
| Iliac Aneurysm | 1 | 2004 | 38 | 0.010 |
Why?
|
| Hospitals, University | 1 | 2006 | 571 | 0.010 |
Why?
|
| Polyethylene Terephthalates | 1 | 2004 | 116 | 0.010 |
Why?
|
| Polytetrafluoroethylene | 1 | 2004 | 233 | 0.010 |
Why?
|
| Health Care Sector | 1 | 2004 | 194 | 0.010 |
Why?
|
| Anastomosis, Surgical | 1 | 2006 | 987 | 0.010 |
Why?
|
| Biomedical Technology | 1 | 2004 | 220 | 0.010 |
Why?
|
| Tomography, Spiral Computed | 1 | 2003 | 280 | 0.010 |
Why?
|
| Equipment Failure | 1 | 2004 | 578 | 0.010 |
Why?
|
| Clinical Trials, Phase II as Topic | 1 | 2004 | 629 | 0.010 |
Why?
|
| Apolipoproteins E | 1 | 2006 | 1438 | 0.010 |
Why?
|
| Hospital Mortality | 1 | 2013 | 5317 | 0.010 |
Why?
|
| Thrombosis | 1 | 2013 | 2968 | 0.010 |
Why?
|
| Algorithms | 1 | 2020 | 13881 | 0.010 |
Why?
|
| Magnetic Resonance Imaging | 2 | 2020 | 35421 | 0.010 |
Why?
|
| Secondary Prevention | 1 | 2006 | 1530 | 0.010 |
Why?
|
| Proportional Hazards Models | 1 | 2013 | 12354 | 0.010 |
Why?
|
| Recurrence | 1 | 2011 | 8340 | 0.010 |
Why?
|
| Fatal Outcome | 1 | 2003 | 1850 | 0.010 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2006 | 4751 | 0.010 |
Why?
|
| Catheterization | 1 | 2004 | 1470 | 0.010 |
Why?
|
| Ultrasonography | 1 | 2011 | 5985 | 0.010 |
Why?
|
| Analysis of Variance | 1 | 2006 | 6365 | 0.010 |
Why?
|
| Equipment Design | 1 | 2003 | 3582 | 0.010 |
Why?
|
| Chronic Disease | 1 | 2009 | 9146 | 0.010 |
Why?
|
| Mice, Knockout | 1 | 2006 | 14557 | 0.010 |
Why?
|
| Multivariate Analysis | 1 | 2003 | 12245 | 0.010 |
Why?
|
| Risk Assessment | 1 | 2011 | 23338 | 0.010 |
Why?
|
| Survival Rate | 1 | 2003 | 12788 | 0.010 |
Why?
|
| Mice, Inbred C57BL | 1 | 2006 | 21827 | 0.000 |
Why?
|
| Predictive Value of Tests | 1 | 2003 | 15076 | 0.000 |
Why?
|
| Severity of Illness Index | 1 | 2003 | 15540 | 0.000 |
Why?
|
| Mice | 1 | 2006 | 81183 | 0.000 |
Why?
|
| Animals | 1 | 2006 | 168757 | 0.000 |
Why?
|